Click it and Unblock the Notifications
Latest Updates
-
₹1000 Crore and Counting: ‘Dhurandhar 2’ Isn’t Just a Hit, It’s a Box Office Phenomenon -
Akshaya Tritiya 2026 Date: April 19 or 20? Know The Right Day To Buy Gold This Year -
From Water Fights to Egg Games: Unique Easter Monday Traditions Explained -
South Indian Perfect Texture Coconut Chutney Recipe -
Horoscope for Today April 06, 2026 - Practical Steps Bring Calm Progress -
Chana Masala Recipe: Experience Dhaba Style Authentic Taste -
Struggling With Oily Skin This Summer? Simple Tips to Keep Shine Under Control -
Garlic Bread Recipe: The Cheesy Bakery Style Trick You Need -
Soha Ali Khan Swears By This ‘Gentle Game-Changer’ Lemon Drink for Gut Health: Full Recipe Inside -
World Health Day 2026: You’re Not As Healthy As You Think—Here’s Why
Antibody-Based Test May Differentiate Zika From Other Infections
Scientists have developed a new antibody-based test that can help differentiate Zika virus infections from infections caused by similar viruses such as dengue and West Nile.
Scientists have developed a new antibody-based test that can help differentiate Zika virus infections from infections caused by similar viruses such as dengue and West Nile.
Zika is a mosquito-borne disease and is linked to severe congenital birth defects.
The new antibody-based test, developed by researchers at the University of California - Berkeley and biotechnology company Humabs BioMed, has very high sensitivity (91.8 per cent) and specificity (95.9 per cent) for identifying Zika virus infections.
"The whole world has been in urgent need of a serological method to distinguish dengue virus from Zika virus infections, and this (is) the first to have such high sensitivity and specificity in dengue-endemic regions," said Eva Harris, Professor at UC-B.
To develop the test, Humabs generated a new human antibody to the Zika virus.
The researchers then implemented the test on samples from Zika patients, with or without prior exposure to dengue virus, and samples from dengue patients infected either once or more than once with different types of the dengue virus.
The data, published in the journal Proceedings of the National Academy of Sciences, showed that the test was highly sensitive, specific and robust.
"These results support that the antibody-based assay that we have developed is highly effective in detecting both recent and past Zika virus infections and in discriminating Zika from other flavivirus infections," said Davide Corti, senior Vice President and Chief Scientific Officer from Humabs BioMed.
"This novel test has the potential to become an effective, simple and low-cost solution for Zika surveillance programs, prevalence studies and clinical intervention trials in flavivirus-endemic areas," Corti added.
Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google